Data Access Commitee of Nanjing Medical University Affiliated Jiangsu Cancer Hospital

Rong Yin
rong_yin@njmu.edu.cn

Request Access

Dataset ID	Description	Technology	Samples
EGAD00001010300	The circulating tumor DNA (ctDNA) mutation-based approach shows limited performance in minimal residual disease (MRD) detection, especially for landmark MRD detection at an early-stage cancer after surgery. Here, A total of 87 NSCLC patients, who received curative surgical resections (23 patients relapsed during follow-up), enrolled in this study. A total of 163 plasma samples, collected at 7 days and 6 months postsurgical, were used for high-throughput sequencing.		1